Supporting liver cancer treatment for uninsured and Medicaid patients
Part of Cancer, Digestive system clinical trials.
This study aims to improve care and access to treatment for people with liver cancer (HCC) who are uninsured or on Medicaid. If you qualify, you may receive assistance and support to ensure you can get the cancer treatment you need.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with hepatocellular carcinoma (HCC), a type of liver cancer, at stage A, B, or C.
- You do not have health insurance, or you have Medicaid as your primary or secondary insurance.
- You plan to receive cancer treatment (not just best supportive care).
- Your planned treatment is not only oral (pill-based) therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at people with advanced liver cancer (HCC) that cannot be removed by surgery. Researchers want to see if certain markers in your blood or tumor can help predict how well you respond to a combination of chemotherapy delivered directly to the liver and immunotherapy. If you join, you will receive the planned treatment and provide additional blood and tissue samples for analysis.
This study looks at why some people with liver cancer are diagnosed at a later stage. Researchers want to understand differences in care and outcomes for patients in certain areas of Los Angeles County.
This trial tests a program to help people with liver cancer get connected to care. It is for patients with specific tumor sizes and numbers, who may face barriers to treatment.
This study aims to improve how patients with liver cancer (hepatocellular carcinoma) get the support and information they need. Researchers will interview patients, caregivers, and healthcare providers to find better ways to navigate care.
This trial tests new treatment plans for people with advanced liver cancer that has worsened after initial therapy. The goal is to find more effective, personalized options based on how your cancer responds.
This study is testing whether combining targeted therapy with immunotherapy (or using two immunotherapies together) can help people with liver cancer that cannot be surgically removed. The goal is to understand how well these treatments work and how they affect biomarkers (signals in your body that show treatment response).
Hear when a new HCC - Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.